Status:
UNKNOWN
Association of Multiple CardiOvascular Risk Factors and Erectile Function Across Europe
Lead Sponsor:
University Hospital, Saarland
Collaborating Sponsors:
Pfizer
Conditions:
Cardiovascular High-Risk
Chronic Heart Failure
Eligibility:
MALE
18+ years
Brief Summary
The purpose of the study is to evaluate the influence of cardiovascular risk factors, heart failure and cardiovascular drug therapy on erectile function in cardiovascular high-risk patients.
Detailed Description
Association of cardiovascular risk factors and ED is likely due to an impairment of endothelial function resulting in a decreased activity of endothelial NO-synthase, which plays a major role in physi...
Eligibility Criteria
Inclusion
- Male patients with two or more cardiovascular risk factors or
- Male patients with a manifestation of atherosclerosis or
- Male patients with an ischemic or dilated cardiomyopathy
- Written informed consent
Exclusion
- Impairment of hormonal status
- Refusal of written informed consent
- Inability to complete the questionnaires
Key Trial Info
Start Date :
May 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2011
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT00468637
Start Date
May 1 2007
End Date
September 1 2011
Last Update
February 16 2009
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiology, University Hospital of the Saarland
Homburg, Saarland, Germany, 66421
2
Gemeinschaftspraxis & Ambulante Tagesklinik
Merzig-Schwemlingen, Saarland, Germany, 66663
3
Section on Cardiovascular Diseases, Department of Experimental and Applied Medicine, University of Brescia
Brescia, Italy
4
Department of Cardiology, 4th Military Clinical Hospital
Wroclaw, Poland